CKD-385 clinical trials
Also written CKD-385.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses CKD-385 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- CKD-385
- 4
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses CKD-385 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed ConditionsStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT04906785Written as CKD-385
- Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting ConditionsStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT04906798Written as CKD-385
- Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT04075643Written as Test drug
- Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy VolunteersStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT03748212Written as CKD-385 Tab. 1T